Yita Lee
Board member
Management
Medigene
Sweden
Biography
Yita Lee currently serves as Chief Scientific Officer of Sinphar Group, a publicly listed company in Taiwan, where he oversees the progress of the company’s R&D projects. As the President of Sinphar’s Subsidiary CanCap Pharmaceutical Ltd., he is in charge of plant manufacturing of pharmaceutical and nutraceutical soft-gelatin products in British Columbia, Canada. Furthermore, he holds positions as Director of SynCore New Drug co., Ltd., and as Director of ZuniMed Biotech Co., Ltd., since 2008 and 2012, respectively. Yita Lee earned his Ph.D. degree at Michael Smith Laboratories & Department of Chemical and Biological Engineering, University of British Columbia. In 2008, he was appointed as director of the Taiwan Bio Industry Organization, as well as director of the Mont Jade Science and Technology Association (Canada) in 2006.
Research Interest
Nutraceutical soft-gelatin products
